Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results

Sandúa Amaia; Macias Monica; Perdomo Carolina; Galofre Juan Carlos; Ferrer Roser; Alegre Estibaliz; González Álvaro

doi:10.1515/almed-2019-0017

Advances in Laboratory Medicine (Jan 2020)

Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results

Sandúa Amaia,
Macias Monica,
Perdomo Carolina,
Galofre Juan Carlos,
Ferrer Roser,
Alegre Estibaliz,
González Álvaro

Affiliations

Sandúa Amaia: Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain
Macias Monica: Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain
Perdomo Carolina: Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain
Galofre Juan Carlos: Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain
Ferrer Roser: Hospital Universitario Vall d’Hebron, Barcelona, Spain
Alegre Estibaliz: Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain
González Álvaro: Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain

DOI: https://doi.org/10.1515/almed-2019-0017
Journal volume & issue: Vol. 1, no. 1
pp. 2783 – 95

Abstract

Read online

Thyroglobulin (Tg) is fundamental for differentiated thyroid cancer (DTC) monitoring. Tg detection can be enhanced using recombinant human thyroid-stimulating hormone (TSH) (rhTSH). This study is aimed to evaluate the use of the rhTSH stimulation test when using a high-sensitivity Tg assay.

Published in Advances in Laboratory Medicine

ISSN: 2628-491X (Online)
Publisher: De Gruyter
Country of publisher: Germany
LCC subjects: Medicine: Medicine (General): Medical technology
Website: https://www.degruyter.com/journal/key/almed/html

About the journal

Abstract

Keywords